JPMA President Opposes Annual NHI Price Revision

November 21, 2014
JPMA President Masayo Tada Masayo Tada, president of the Japanese Pharmaceutical Manufacturers Association (JPMA), voiced strong opposition to an annual revision of NHI drug prices on November 20, saying that the current biennial revision should be maintained. Pharmaceutical companies’ core...read more